Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptor 8 (TLR8) is an endosomal pattern recognition receptor that belongs to the Toll-like receptor family. It plays a critical role in the innate immune system by recognizing single-stranded RNA (ssRNA) from viruses and other pathogens, as well as RNA degradation products. Upon activation, TLR8 triggers intracellular signaling cascades via MyD88, leading to the production of proinflammatory cytokines and the activation of immune cells. TLR8 is primarily expressed in monocytes, macrophages, lung tissue, and peripheral blood leukocytes. It also exhibits a role in neurons where its function remains under investigation, though it is thought to be involved in neurite outgrowth and neuropathic pain. Due to its role in immune activation, TLR8 is a potential therapeutic target for vaccine development and cancer immunotherapy. Conversely, TLR8 antagonists may be useful for treating diseases characterized by excessive inflammation.
TLR8 agonists bind to the receptor in endosomes, leading to MyD88 recruitment, NF-kB activation, and production of proinflammatory cytokines. TLR8 antagonists inhibit this signaling pathway.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 8 (TLR8).